Tag archive for ‘oritavancin’
Trius’ (TSRX) Tedizolid Has Blockbuster Potential for MRSA Infections
Trius Therapeutics TSRX) is in late stage clinical development of its new antibiotic, tedizolid, for treatment of MRSA infections that have increased to epidemic levels in both the hospital and community settings. There are a number of companies competing in this market and a host of new products in development, but I see tedizolid as […]